**Meet the editor**

Jan Oxholm Gordeladze, PhD (born on April 25th, 1950), holds a triple professor competence (medical biochemistry, physiology, and pharmacology) and is presently working as a professor at the Institute of Basic Medical Science, Department of Molecular Medicine, Section for Biochemistry, University of Oslo, Norway. He has previously been employed as the medical director of Merck

Sharp & Dohme (MSD), Norway, serving two years as a Fulbright scholar at the NIH, Bethesda, Maryland, USA, and from 2006 to 2009, he has been employed as associate professor at the University of Montpellier, France. He has published more than 130 scientific articles and reviews/book chapters and presented more than 260 abstracts/posters/talks at conferences worldwide. At present, he and his research team are focused on research related to stem cell differentiation, cell phenotype stabilization by manipulating regulatory looping systems consisting of key genes and microR-NAs, as well as the impact of vitamin K2 on cellular and organ functions, including osteoblasts (bone), chondrocytes (cartilage), striated muscle cells (skeletal muscle), and adipocytes (white and brown fat tissues).
